Placebo reactions in a study of lysergic acid diethylamide (LSD-25).

Effect of lysergic acid diethylamide (LSD-25) on morphine induced bradycardia.

Several antagonistic interactions between morphine and LSD-25 (lysergic acid diethylamide) have been demonstrated. LSD-25 antagonizes morphine induced analgesia in rats (1) and emesis in dogs (2). It also blocks the miotic action of morphine (3). On the other hand morphine blocks LSD-25 induced pyre xia in rabbits (4) and the central hypotensive effect of LSD-25 in dogs (5). Morphine produces m...

D-lysergic acid diethylamide (LSD-25): a survey of the literature.

Response of cluster headache to psilocybin and LSD.

The authors interviewed 53 cluster headache patients who had used psilocybin or lysergic acid diethylamide (LSD) to treat their condition. Twenty-two of 26 psilocybin users reported that psilocybin aborted attacks; 25 of 48 psilocybin users and 7 of 8 LSD users reported cluster period termination; 18 of 19 psilocybin users and 4 of 5 LSD users reported remission period extension. Research on th...

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

A double-blind, randomized, active placebo-controlled pilot study was conducted to examine safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients with anxiety associated with life-threatening diseases. Treatment included drug-free psychotherapy sessions supplemented by two LSD-assisted psychotherapy sessions 2 to 3 weeks apart. The participants received ei...

The Effects of D-lysergic Acid Diethylamide Tartrate (lsd-25) on the Cholinesterases and Monoamine Oxidase in the Spinal Cord: a Possible Factor in the Mechanism of Hallucination.